Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain andN-Terminal Domain mRNA Vaccine.
Chalkias S, Pragalos A, Akinsola A, Berman G, Ampajwala M, Meyer J, Schoch L, Zhou W, Paila YD, Deng W, Feng J, de Windt E, Edwards D, Miller J, Das R.
Chalkias S, et al. Among authors: zhou w.
J Infect Dis. 2025 Jan 10:jiaf022. doi: 10.1093/infdis/jiaf022. Online ahead of print.
J Infect Dis. 2025.
PMID: 39792478